Health Condition 1: null- Carpal Tunnel Syndrome
Conditions
Interventions
Intervention1: Methyl prednisolone 40mg/ml: Each participant will be randomized to receive active intervention at one of the sites ie.either proximal or distal.If in a patient randomization is coming
Sponsors
JIPMER
Eligibility
Inclusion criteria
Inclusion criteria: patients coming to Neurology OPD with symptoms & signs of CTS of atleast 3 months with atleast one of the following electrophysiology features Median motor distal Latency >4.5 ms Difference in Median and Ulnar motor distal latency >0.5ms Median sensory latency >3.4ms Difference in Median and Ulnar sensory peak Latency >0.5ms
Exclusion criteria
Exclusion criteria: Severe CTS with thenar atrophy 18 years of age Not willing to participate/give consent Contraindications for corticosteroid injections (eg: skin infection at site) Traumatic/Neoplastic origin of symptoms
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The CTS symptom severity score (SSS)change at 1 month after treatment. Timepoint: The CTS symptom severity score (SSS)change at 1 month after treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| The CTS SSS changes at 3 month Direct treatment response at 1 month(physician) Improvement as perceived by patient Proportion of patients referred for surgery Adverse events Time taken for the procedure Pain perceived during the procedure Timepoint: at the time of procedure 2 weeks,1 month,3 months after injection | — |
Countries
India
Contacts
Public ContactDrPradeep P Nair
Jawaharlal Institute of Post graduate Medical Education and Research
Outcome results
None listed